The Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-19
Matsuo So, Hiroki Kabata, Mai Takahashi, Natalia Egorova, Toshiki Kuno
Abstract
Journal of Aerosol Medicine and Pulmonary Drug DeliveryVol. 34, No. 4 Letters to the EditorThe Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-19Matsuo So, Hiroki Kabata, Mai Takahashi, Natalia N. Egorova, and Toshiki KunoMatsuo SoDepartment of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York, USA.Search for more papers by this author, Hiroki KabataDepartment of Pulmonary Medicine, Keio University School of Medicine, Tokyo, Japan.Search for more papers by this author, Mai TakahashiDepartment of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York, USA.Search for more papers by this author, Natalia N. EgorovaDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.Search for more papers by this author, and Toshiki KunoAddress for correspondence: Toshiki Kuno, MD, PhD, Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, First Avenue, 16th street, New York, NY 10003, USA E-mail Address: [email protected]https://orcid.org/0000-0002-2487-8366Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York, USA.Search for more papers by this authorPublished Online:3 Aug 2021https://doi.org/10.1089/jamp.2021.0020AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookXLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byFactors associated with improved outcome of inhaled corticosteroid use in COVID-19: A single institutional studyMedicine, Vol. 101, No. 51Could inhaled corticosteroids be the game changers in the prevention of severe COVID-19? A review of current evidencePanminerva Medica, Vol. 64, No. 3The association of anticoagulation before admission and survival of patients with COVID-19Journal of Cardiology, Vol. 79, No. 4The association of statins use with survival of patients with COVID-19Journal of Cardiology, Vol. 79, No. 4The association between famotidine and in‐hospital mortality of patients with COVID‐1911 October 2021 | Journal of Medical Virology, Vol. 94, No. 3Prediction of in‐hospital mortality with machine learning for COVID‐19 patients treated with steroid and remdesivir22 October 2021 | Journal of Medical Virology, Vol. 94, No. 3Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid15 September 2021 | Journal of Thrombosis and Thrombolysis, Vol. 53, No. 2The association of hemoglobin drop with in-hospital outcomes in COVID-19 patients1 October 2021 | QJM: An International Journal of Medicine, Vol. 114, No. 11The effect of obesity on in-hospital mortality among patients with COVID-19 receiving corticosteroidsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, Vol. 16, No. 1 Volume 34Issue 4Aug 2021 InformationCopyright 2021, Mary Ann Liebert, Inc., publishersTo cite this article:Matsuo So, Hiroki Kabata, Mai Takahashi, Natalia N. Egorova, and Toshiki Kuno.The Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-19.Journal of Aerosol Medicine and Pulmonary Drug Delivery.Aug 2021.265-267.http://doi.org/10.1089/jamp.2021.0020Published in Volume: 34 Issue 4: August 3, 2021Online Ahead of Print:June 11, 2021PDF download